GW Pharmaceuticals plc Income Statement 2011-2024 | GWPH

Annual Income Statement GW Pharmaceuticals plc

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	4.79 B	41.9 B	3.67 B	2.68 B	2.64 B	1.62 B	1.24 B	387 M	-	-
Shares	31.4 M	372 M	27.8 M	25.3 M	22.6 M	20.5 M	17.5 M	12.6 M	-	-
Net Income	-58.1 M	-9.02 M	-295 M	-176 M	-82.9 M	-67.5 M	-23.8 M	-7.35 M	4.02 M	4.29 M
Revenue	527 M	311 M	12.7 M	11 M	13.4 M	43.2 M	48.8 M	44.1 M	53.5 M	46.2 M
EBITDA	-39 M	-109 M	-280 M	-191 M	-141 M	-92.6 M	-34.8 M	-15.3 M	2.9 M	4.3 M
Operating Expenses	541 M	403 M	296 M	205 M	156 M	135 M	82.5 M	59 M	50.4 M	40.7 M
General and Administrative Expenses	336 M	260 M	-	-	-	-	11.9 M	6.13 M	-	1.22 M

All numbers in USD currency